scispace - formally typeset
Search or ask a question
Topic

Withania somnifera

About: Withania somnifera is a research topic. Over the lifetime, 2116 publications have been published within this topic receiving 43404 citations. The topic is also known as: Ashwaganda & Indian ginseng.


Papers
More filters
Journal Article
TL;DR: The present work initiated to study the endophytic fungal population in Withania somnifera (L.) Dunal, a commonly used medicinal plant in the subcontinent, and found most dominant endophyte was found to be A. alternata.
Abstract: Withania somnifera (L.) Dunal is known to possess medicinal properties. Medicinal plants harbour endophytic mycoflora. Only a few plants have been studied for their endophyte biodiversity and their potential to produce bioactive secondary metabolites. There is a need to understand the biodiversity of endophytic fungi and their potential of producing novel compounds of medicinal importance. A total of 643 segments (202 leaf, 391 stem, and 50 root samples) from 20 different plants were screened for their endophytic mycoflora. Thirty-three fungal strains of 24 species have been isolated, four belonged to the class Ascomycetes and 20 to class Deuteromycetes. The highest species richness as well as frequency of colonization was in stem; with the exception of Aspergillus niger, A. terreus and A. alternata, all the other fungi were found to be organ-specific. In this study most dominant endophyte was found to be A. alternata. Overall colonization frequency was measured as 14.15%. Many of the pharmaceutical compounds produced by medicinal plants are reportedly produced by their endophytic fungi. Hence, it is important to study medicinal plants for their endophytic mycoflora for biodiversity and then to determine their medicinal properties. The present work was therefore initiated to study the endophytic fungal population in Withania somnifera (L.) Dunal., a commonly used medicinal plant in the subcontinent.

72 citations

Journal ArticleDOI
03 Feb 2014-PLOS ONE
TL;DR: Taking into account that sub-cytotoxic concentrations of WA target multiple metastatic effectors in therapy-resistant triple negative breast cancer, WA-based therapeutic strategies targeting the uPA pathway hold promise for further (pre)clinical development to defeat aggressive metastatic breast cancer.
Abstract: Withaferin A (WA) isolated from Withania somnifera (Ashwagandha) has recently become an attractive phytochemical under investigation in various preclinical studies for treatment of different cancer types. In the present study, a comparative pathway-based transcriptome analysis was applied in epithelial-like MCF-7 and triple negative mesenchymal MDA-MB-231 breast cancer cells exposed to different concentrations of WA which can be detected systemically in in vivo experiments. Whereas WA treatment demonstrated attenuation of multiple cancer hallmarks, the withanolide analogue Withanone (WN) did not exert any of the described effects at comparable concentrations. Pathway enrichment analysis revealed that WA targets specific cancer processes related to cell death, cell cycle and proliferation, which could be functionally validated by flow cytometry and real-time cell proliferation assays. WA also strongly decreased MDA-MB-231 invasion as determined by single-cell collagen invasion assay. This was further supported by decreased gene expression of extracellular matrix-degrading proteases (uPA, PLAT, ADAM8), cell adhesion molecules (integrins, laminins), pro-inflammatory mediators of the metastasis-promoting tumor microenvironment (TNFSF12, IL6, ANGPTL2, CSF1R) and concomitant increased expression of the validated breast cancer metastasis suppressor gene (BRMS1). In line with the transcriptional changes, nanomolar concentrations of WA significantly decreased protein levels and corresponding activity of uPA in MDA-MB-231 cell supernatant, further supporting its anti-metastatic properties. Finally, hierarchical clustering analysis of 84 chromatin writer-reader-eraser enzymes revealed that WA treatment of invasive mesenchymal MDA-MB-231 cells reprogrammed their transcription levels more similarly towards the pattern observed in non-invasive MCF-7 cells. In conclusion, taking into account that sub-cytotoxic concentrations of WA target multiple metastatic effectors in therapy-resistant triple negative breast cancer, WA-based therapeutic strategies targeting the uPA pathway hold promise for further (pre)clinical development to defeat aggressive metastatic breast cancer.

72 citations

Journal Article
TL;DR: It is concluded that this ethanolic extract of Withania somnifera has useful anxiolytic potential and merits further investigation.
Abstract: A double-blind, placebo-controlled study was conducted to evaluate the efficacy an ethanolic extract of Aswagandha (Withania somnifera), in patients with ICD-10 anxiety disorders. The sample comprised 39 subjects, of whom 20 received the drug and 19 received placebo. The two groups were sociodemographically and clinically similar at baseline. At 2 and 6 weeks follow-up, data from approximately 85% of patients in each group were available for analysis. Statistical trends favouring the drug were observed at both time points. At 6 weeks, significantly more patients met a priori response criteria in the drug group (88.2%) as compared with the placebo group (50%). The drug was well-tolerated and did not occasion more adverse effects than did placebo. It is concluded that this ethanolic extract of Withania somnifera has useful anxiolytic potential and merits further investigation.

72 citations

Journal ArticleDOI
TL;DR: In this paper, the anti-diabetic activity of W. somnifera extract and purified withanolides, as well as the effect of various elicitors on this activity were evaluated.

72 citations

Journal ArticleDOI
TL;DR: Exposure of MDA-MB-231 and MCF-7 human breast cancer cells to WA resulted in suppression of XIAP, cIAP-2, and Survivin protein levels, which indicates important contribution of Survivin suppression in WA-induced apoptosis.

71 citations


Network Information
Related Topics (5)
Antioxidant
37.9K papers, 1.7M citations
79% related
Essential oil
32.6K papers, 625.2K citations
78% related
Gallic acid
9.6K papers, 287K citations
78% related
Quercetin
7.7K papers, 333.3K citations
78% related
Antibacterial activity
18.4K papers, 322.4K citations
78% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
2023114
2022265
202188
2020124
201995
2018111